Global Trial Registration Transparency Initiative Gains Momentum
New EU regulations mandate real-time data sharing, reshaping how pharmaceutical companies conduct multicenter studies.
Read Analysis →
Drug Development
Phase III Trial Shows 89% Efficacy for Next-Gen Alzheimer’s Therapy
In a landmark double-blind study spanning 12 countries, researchers report unprecedented cognitive stabilization in early-stage patients. The FDA has fast-tracked review for potential breakthrough designation.
Clinical Trials
Biotech & Genomics
CRISPR 3.0 Enables Precision Gene Editing Without Off-Target Effects
MIT team unveils novel guide-RNA architecture that dramatically improves therapeutic accuracy in vivo.
Read Analysis →
Regulatory & Policy
WHO Updates Guidelines for Adaptive Trial Designs in Rare Diseases
New framework reduces trial duration by up to 40% while maintaining statistical rigor for orphan drug approvals.
Read Analysis →
Research Ethics
AI-Driven Patient Recruitment Raises Privacy and Consent Debates
As machine learning accelerates trial matching, bioethicists call for standardized data governance protocols.
Read Analysis →
Drug Development
Novel mRNA Platform Shows Promise for Autoimmune Disorder Treatment
Early-phase data suggests targeted immune modulation without broad immunosuppression, marking a potential paradigm shift.
Read Analysis →
Clinical Trials
Real-World Evidence Integration Gains FDA Acceptance for Oncology Trials
Regulators expand pathways to incorporate digital health data, accelerating oncology drug approvals by up to 18 months.
Read Analysis →Our Clinical Reporting Standards
Aevum News applies rigorous medical journalism protocols to ensure accuracy, context, and scientific integrity.
⚕️ Expert Peer Review
Every clinical article is reviewed by at least one MD/PhD or registered clinical researcher before publication.
📊 Data Verification
Statistical claims, p-values, and confidence intervals are cross-checked against original trial publications.
⚖️ Conflict Disclosure
Full funding sources, trial sponsorships, and author affiliations are transparently disclosed per COPE guidelines.